EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.27X leverage
Performance
- Low
- ₹1,396
- High
- ₹1,442
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,520
- Open Price₹1,416
- Previous Close₹1,411
- Volume106,491
Investment Returns
- Over 1 Month + 0.46%
- Over 3 Month + 7.71%
- Over 6 Month + 6.93%
- Over 1 Year + 0.51%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.1
- PEG Ratio
- 0.9
- Market Cap Cr
- 27,071
- P/B Ratio
- 5.7
- Average True Range
- 42.9
- EPS
- 42.32
- Dividend Yield
- 0.2
- MACD Signal
- 6.69
- RSI
- 56.69
- MFI
- 65.62
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,428.00
+
16.9
(1.2%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,400.22
- 50 Day
- ₹1,387.09
- 100 Day
- ₹1,366.63
- 200 Day
- ₹1,346.37
Resistance and Support
1422.1
- R3 1,493.60
- R2 1,467.80
- R1 1,447.90
- S1 1,402.20
- S2 1,376.40
- S3 1,356.50
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,428 As on 27 December, 2025 | 02:18
The Market Cap of Emcure Pharmaceuticals is ₹27071 Cr As on 27 December, 2025 | 02:18
The P/E ratio of Emcure Pharmaceuticals is 34.1 As on 27 December, 2025 | 02:18
The PB ratio of Emcure Pharmaceuticals is 5.7 As on 27 December, 2025 | 02:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.